The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).
 
Ahmet Bilici
No Relationships to Disclose
 
Omer Fatih Olmez
No Relationships to Disclose
 
Ahmet Sezer
Honoraria - Amgen (Inst); pfizer (Inst); Roche (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Pfizer; Roche
Research Funding - Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Berna Oksuzoglu
No Relationships to Disclose
 
Muhammet Ali Kaplan
No Relationships to Disclose
 
Nuri Karadurmus
No Relationships to Disclose
 
Erdem Cubukcu
No Relationships to Disclose
 
Mehmet A.N. Sendur
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
 
Sercan Aksoy
No Relationships to Disclose
 
Dilek Erdem
No Relationships to Disclose
 
Gul Basaran
No Relationships to Disclose
 
Burcu Cakar
No Relationships to Disclose
 
Mesut Seker
No Relationships to Disclose
 
Cagatay Arslan
No Relationships to Disclose
 
Sema Sezgin Goksu
No Relationships to Disclose
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Astellas Pharma; Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Mahmut Gumus
Honoraria - MSD Oncology (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Fatih Selcukbiricik
No Relationships to Disclose
 
Hakan Harputluoglu
No Relationships to Disclose
 
Kaan Helvaci
No Relationships to Disclose